Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
2009
A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
2016
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
2007
Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
2008
Transcriptional Regulation by Nrf2
2017 Standout
Breast cancer
2019 Standout
Arresting a Transient Receptor Potential (TRP) Channel
2010 StandoutNobel
PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia
2016 StandoutNobel
Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?
2018
Head and neck squamous cell carcinoma
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression
2009
Increased CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner
2019
Hepatocellular carcinoma
2016 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer
2011
Regulation of the human thioredoxin gene promoter and its key substrates: A study of functional and putative regulatory elements
2013
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Significance of Nuclear Accumulation of Foxo3a in Esophageal Squamous Cell Carcinoma
2008
Modulation of oxidative stress as an anticancer strategy
2013 Standout
FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice
2017
The biology and function of fibroblasts in cancer
2016 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling
2019
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
The molecular machinery of regulated cell death
2019 Standout
Targeted therapies in bladder cancer: an overview of in vivo research
2015
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
2016
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Role of interleukin-6 in cancer progression and therapeutic resistance
2016
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Clinical Outcomes of Intensity-Modulated Pelvic Radiation Therapy for Carcinoma of the Cervix
2010
T-Cell Activation under Hypoxic Conditions Enhances IFN-γ Secretion
2009 StandoutNobel
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Galectin-3 contributes to cisplatin-induced myeloid derived suppressor cells (MDSCs) recruitment in Lewis lung cancer-bearing mice
2014
Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells
2011
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
2010
Tumor-induced CD14+HLA-DR−/low myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients
2014
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
2013
Cancer-related inflammation and treatment effectiveness
2014 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
Myeloid-Derived Suppressor Cells in Bacterial Infections
2016
Cervical cancer
2019 Standout
No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome
2011 StandoutNobel
1α, 25 Dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC)
2019
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
β-arrestin-mediated receptor trafficking and signal transduction
2011 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Thioredoxins, Glutaredoxins, and Peroxiredoxins—Molecular Mechanisms and Health Significance: from Cofactors to Antioxidants to Redox Signaling
2013
The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy
2012
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
2011
IL-6-stimulated CD11b+CD14+HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
2014
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Human prx1 Gene Is a Target of Nrf2 and Is Up-regulated by Hypoxia/Reoxygenation: Implication to Tumor Biology
2007
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
2014
The Therapeutic Potential of Apigenin
2019 Standout
Bladder Cancer
2020 Standout
Elevated Peroxiredoxin 1, but not NF-E2–Related Factor 2, Is an Independent Prognostic Factor for Disease Recurrence and Reduced Survival in Stage I Non–Small Cell Lung Cancer
2007
Signal transduction by reactive oxygen species
2011 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
2016
Transcriptional regulation of myeloid-derived suppressor cells
2015
Myeloid‐derived suppressor cells: the dark knight or the joker in viral infections?
2013
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells
2013
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Peroxiredoxin 1 Controls Prostate Cancer Growth through Toll-Like Receptor 4–Dependent Regulation of Tumor Vasculature
2011
Identification of βArrestin2 as a corepressor of androgen receptor signaling in prostate cancer
2009
Region-Specific Growth Effects in the Developing Rat Prostate Following Fetal Exposure to Estrogenic Ultraviolet Filters
2008
Inflammation and prostate cancer: the role of interleukin 6 ( IL ‐6)
2013
Peroxiredoxin 1 Interacts with Androgen Receptor and Enhances Its Transactivation
2007
Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review)
2019
Works of Chun‐Te Wu being referenced
1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
2015
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
2008
Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells
2005
The role of IL-6 in the radiation response of prostate cancer
2013
The role of PD-L1 in the radiation response and clinical outcome for bladder cancer
2016
Thrombomodulin expression regulates tumorigenesis in bladder cancer
2014
IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
2013
Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression
2006
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
2008
Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer
2003
Adjuvant Concurrent Chemoradiotherapy With Intensity-Modulated Pelvic Radiotherapy After Surgery for High-Risk, Early Stage Cervical Cancer Patients
2008
Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells
2012
Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor
2007
Androgen Receptor (AR) NH2- and COOH-Terminal Interactions Result in the Differential Influences on the AR-Mediated Transactivation and Cell Growth
2004